414 related articles for article (PubMed ID: 30982078)
1. Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma.
Ruckert MT; de Andrade PV; Santos VS; Silveira VS
Cell Mol Life Sci; 2019 Jul; 76(13):2571-2592. PubMed ID: 30982078
[TBL] [Abstract][Full Text] [Related]
2. Impact of oncogenic protein tyrosine phosphatases in cancer.
Hardy S; Julien SG; Tremblay ML
Anticancer Agents Med Chem; 2012 Jan; 12(1):4-18. PubMed ID: 21707506
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatases, new targets for cancer therapy.
Easty D; Gallagher W; Bennett DC
Curr Cancer Drug Targets; 2006 Sep; 6(6):519-32. PubMed ID: 17017875
[TBL] [Abstract][Full Text] [Related]
4. Targeting PTPs with small molecule inhibitors in cancer treatment.
Jiang ZX; Zhang ZY
Cancer Metastasis Rev; 2008 Jun; 27(2):263-72. PubMed ID: 18259840
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
6. Kinase signaling pathways as targets for intervention in pancreatic cancer.
Preis M; Korc M
Cancer Biol Ther; 2010 May; 9(10):754-63. PubMed ID: 20234186
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.
Frankson R; Yu ZH; Bai Y; Li Q; Zhang RY; Zhang ZY
Cancer Res; 2017 Nov; 77(21):5701-5705. PubMed ID: 28855209
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatases in cancer: friends and foes!
Labbé DP; Hardy S; Tremblay ML
Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase D enzymes: novel kinase targets in pancreatic cancer.
Liou GY; Storz P
Expert Rev Gastroenterol Hepatol; 2015; 9(9):1143-6. PubMed ID: 26174103
[TBL] [Abstract][Full Text] [Related]
11. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
12. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
14. Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma.
Sahu N; Chan E; Chu F; Pham T; Koeppen H; Forrest W; Merchant M; Settleman J
Mol Cancer Ther; 2017 Sep; 16(9):1729-1738. PubMed ID: 28619758
[TBL] [Abstract][Full Text] [Related]
15. Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer.
Mace TA; Shakya R; Elnaggar O; Wilson K; Komar HM; Yang J; Pitarresi JR; Young GS; Ostrowski MC; Ludwig T; Bekaii-Saab T; Bloomston M; Lesinski GB
Oncotarget; 2015 Dec; 6(42):44509-22. PubMed ID: 26575024
[TBL] [Abstract][Full Text] [Related]
16. Targeting protein tyrosine phosphatases for anticancer drug discovery.
Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer.
Ding L; Billadeau DD
Expert Opin Ther Targets; 2020 May; 24(5):417-426. PubMed ID: 32178549
[No Abstract] [Full Text] [Related]
18. Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer.
Bollu LR; Mazumdar A; Savage MI; Brown PH
Clin Cancer Res; 2017 May; 23(9):2136-2142. PubMed ID: 28087641
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatases as novel targets in breast cancer therapy.
Nunes-Xavier CE; Martín-Pérez J; Elson A; Pulido R
Biochim Biophys Acta; 2013 Dec; 1836(2):211-26. PubMed ID: 23756181
[TBL] [Abstract][Full Text] [Related]
20. Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion.
Jiang H; Liu X; Knolhoff BL; Hegde S; Lee KB; Jiang H; Fields RC; Pachter JA; Lim KH; DeNardo DG
Gut; 2020 Jan; 69(1):122-132. PubMed ID: 31076405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
